The Stroke Risks:
At the conclusion of the session, learners should be better prepared to:
- Role of hypertension as a stroke risk factor;
- Treatment of hypertension to reduce stroke risk;
- Relevance to the stroke belt.
The Heart Risks:
Sudden unexpected death accounts for over 10% of premature natural deaths for younger adults. Sudden death is more common in rural communities and is associated with coronary artery disease, hypertension, diabetes and chronic respiratory disease. This lecture will review what we know about sudden death in southern and rural communities. Specifically, we will review the clinical, environmental and social risk factors for sudden death and will outline prevention strategies that we, our families and our communities might take to reduce sudden death incidence. At the conclusion of the session, learners should be better prepared to:
- Describe the public health burden of sudden death;
- Describe the clinical, social and environmental risk factors for sudden death;
- Appreciate individual, family and community prevention efforts that may reduce the burden of sudden unexpected death.
The Kidney Risks:
This session will review the risk factors for developing chronic kidney disease and subsequent end stage kidney disease and the high prevalence of these in the southern part of the United States. While many of these are inherited for which nothing can be done, there are many, such as hypertension, type 2 diabetes mellitus, obesity, excessive analgesic use and others, that can be modified. Such knowledge can help the physician prevent CKD in his or her patients. At the conclusion of the session, learners should be better prepared to:
- Have improved competency at recognizing patients’ risk factors for developing chronic kidney disease and for end stage renal disease.
CME Release Date: January 4, 2019
Valid for credit through: January 4, 2020
Course type: Video lecture
Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Southern Medical Association designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. All healthcare professionals who are not MDs or DOs will receive a certificate of participation.
Instructions for Participation and Credit
To successfully earn credit, participants must complete the activity online during the valid credit period noted, following these steps:
- Read the goals and objectives, accreditation information, and author disclosures.
- View the educational video of the lecture.
- Study the educational references.
- Online, choose the best answer to each test question. Learners must receive a passing score of 80%.
- Complete the activity evaluation and outcomes.
Upon successful completion of the test, evaluation and attestation, your certificate will be processed and emailed from email@example.com within approximately 1 hour. Credits will be archived for 6 years; at any point within this time period you may login to your account to print a duplicate copy of your certificate.
Click the Disclosure Tab above for Faculty Information
Disclosure of Relevant Financial Relationships
As an organization accredited by the ACCME, Southern Medical Association requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest.
Southern Medical Association encourages Speakers/Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Souvik Sen, MD
Souvik Sen, MD, MS, MPH, currently serves as Chair of Neurology at Palmetto Health-USC Neurology and is a professor of neurology with the University of South Carolina School of Medicine. He joined the University of South Carolina School of Medicine in January, 2010.
Dr. Sen earned his medical degree from the University of Calcutta R. G. Kar Medical College in Calcutta, India. After completing medical training in India, he completed a Masters in Science in cardiovascular pharmacology at Wayne State University in Detroit, and then completed a medical internship at Henry Ford Hospital, also in Detroit. He completed a neurology residency at Temple University Health Science Center in Philadelphia, and a vascular neurology fellowship at Johns Hopkins University Hospital in Baltimore. After his fellowship he served as co-director and subsequently director of the stroke center at the NJ Neuroscience Institute in Edison, New Jersey. He then served as the founding director of the UNC Hospitals Comprehensive Stroke Center at the University of North Carolina in Chapel Hill. While there, he completed a Masters in Public Health with an epidemiology major.
Dr. Sen is board certified in neurology, and subspecialty board certified in Vascular Neurology. He is a recipient of the prestigious Center of Economic Excellence Stroke Chair in South Carolina, and has published in peer reviewed journals including Circulation, Stroke and the New England Journal of Medicine. He has received research funding from the American Heart Association and the National Institutes of Health. In 2004, he was nominated as a Fellow of the American Heart Association. He serves on several national and international committees, and his specific research interests include acute stroke treatment, stroke and TIA pathophysiology, stroke prevention and epidemiology.
- Dr. Sen has no relevant financial relationships to disclose:
- Dr. Sen does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
Michael Moore, MD
Michael A. Moore, MD, FACP, FAHA, is a nephrologist from Danville, VA. He is member of the Hypertension & Vascular Disease Center of the Wake Forest University School of Medicine and the faculties of the Virginia College of Osteopathic Medicine and the Liberty University Colleges of Osteopathic Medicine. After receiving his MD degree at the University of North Carolina, his Internal Medicine and Nephrology training were completed at The Johns Hopkins Hospital. Dr. Moore is a Fellow of the American Heart Association and the American Society of Hypertension, which recognizes him as a Hypertension Specialist. He participated in the preparation of the Fourth, Fifth, Sixth, and Seventh Joint National Committee Reports on the Detection, Evaluation, and Management of High Blood Pressure (JNCs) as well as other national clinical guidelines on cardiovascular disease. He chaired the National Heart, Lung, & Blood Institute’s Working Group on Detection, Treatment, and Prevention of Hypertensive Renal Disease.
Dr. Moore is a nationally recognized teacher on hypertension and cardiovascular disease. He is a previous Teacher of the Year at the Wake Forest School of Medicine and an American Heart Association national Physician of the Year which recognized his dedication to patient care, years of providing medical education, and the development of 2 nonprofit voluntary cardiovascular improvement organizations, DRChip & COSEHC. Dr. Moore was instrumental in developing the residency programs at Sovah Health in Danville, VA, which named its education building, the Michael A. Moore, MD Clinical Education Center.
- Dr. Moore has the following relevant financial relationships to disclose:
- Sovah Health/Employee
- Dr. Moore does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
Ross J. Simpson, Jr., MD, PhD
Dr. Simpson is Professor of Medicine and Clinical Professor of Epidemiology at the University of North Carolina, Chapel Hill. Dr. Simpson completed his medical degree at Georgetown University School of Medicine in Washington, DC, and followed that with an internship and residency in internal medicine and a fellowship in cardiology at the University of Illinois Hospital in Chicago. He received both his PhD and MPH in Epidemiology from the UNC School of Public Health.
Dr. Simpson is Board Certified in Internal Medicine and Cardiovascular Disease and certified by the National Board of Medical Examiners. He is a Fellow of the American College of Cardiology and the American College of Physicians and a Fellow of the National Lipid Association. Dr. Simpson is principal investigator of SUDDEN, a population-based study of the epidemiology of all-cause, out-of-hospital, sudden unexpected death (OHSUD) in adults under age 65. His other areas of research interest include the management of hypercholesterolemia, hypertension, and cardiovascular disease, and he has lectured nationally and internationally on these topics. His work is widely published, and he serves as a reviewer for numerous medical publications.
- Dr. Simpson has the following relevant financial relationships to disclose:
- Pfizer/honorarium, travel/mock FDA meeting participant
- Cherops/consulting fee/review research data and edit report
- Innovative Science Solutions/honorarium, travel/participant in mock FDA meeting on new drug development
- Dr. Simpson does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
Jan Basile, MD
Dr. Basile earned his medical degree from the Medical College of Virginia in Richmond. He then completed his internship and residency at the Medical University of South Carolina in Charleston, where he was also Chief Resident. He is board certified in internal medicine and is a Fellow of the American College of Physicians (FACP), the American Society of Hypertension (FASH), and the American Heart Association (FAHA). For many years he served on the American Society of Hypertension (ASH) Board of Directors, and with the recent dissolution of ASH, he is serving within the AHA as Vice-Chair of Clinical Programs on the Council of Hypertension.
His many honors and awards include the Medical University of South Carolina School of Medicine Excellence in Teaching award, the Golden Apple award, and, in 2014, he was the first recipient of the SC Department of Health and Environmental Control Hypertension Physician of the Year award. He was President of the Southern Medical Association from 2008-2009.
Currently, he is Professor of Medicine at the Medical University of South Carolina (MUSC). For the past 9 years he has volunteered at the Ralph H Johnson VA Medical Center. Prior to this, he spent 31 years at the VA while faculty at MUSC having retired as Chief of Primary Care in 2009. He continues to direct the resistant hypertension clinic within the Seinsheimer Cardiovascular Health Program, a multi-risk factor lipid and resistant hypertension referral clinic at MUSC.
- Dr. Basile has the following relevant financial relationships to disclose:
- Medtronic/consultant/advisory board
- ReCor/consultant/advisory board
- Up-to-date/consultant/advisory board
- Dr. Basile does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
Carlos Ferrario, MD
Carlos M. Ferrario, MD, is a cardiologist whose research has advanced understanding and treatment of high blood pressure and vascular disease. A graduate of the University of Buenos Aires Medical School in 1963, Dr. Ferrario pursued postgraduate training in cardiology at the University of Goteborg and the Karolinska Institute in Sweden between 1964 and 1966 and then joined Dr. Irvine H. Page, a pioneer in hypertension research, at The Cleveland Clinic Foundation in 1966. Dr. Ferrario developed a premier program on the neural and endocrine causes of hypertension chairing the Department of Brain and Vascular Research of the Cleveland Clinic Foundation from 1984 to 1992. He founded the Hypertension and Vascular Research Center at the Wake Forest University School of Medicine in 1992, serving as its Director until 2009.
- Dr. Ferrario has no following relevant financial relationships to disclose.
- Dr. Ferrario does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
The following planning committee members have no relevant financial relationships to declare:
Donald DiPette, MD
Daniel Lackland, MD
Jennifer Price, MA, SMA CME Program Manager
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase purchase access to this course.